AR070212A1 - Derivados de 4-(pirrolo[2,3-c]piridin-3-il)-pirimidinil-2-amina, proceso de preparacion, medicamentos que los contienen y usos de los mismos para el tratamiento de tumores, metastasis tumoral y/o sida. - Google Patents
Derivados de 4-(pirrolo[2,3-c]piridin-3-il)-pirimidinil-2-amina, proceso de preparacion, medicamentos que los contienen y usos de los mismos para el tratamiento de tumores, metastasis tumoral y/o sida.Info
- Publication number
- AR070212A1 AR070212A1 ARP090100174A ARP090100174A AR070212A1 AR 070212 A1 AR070212 A1 AR 070212A1 AR P090100174 A ARP090100174 A AR P090100174A AR P090100174 A ARP090100174 A AR P090100174A AR 070212 A1 AR070212 A1 AR 070212A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- hal
- tumor
- pirimidinil
- pirrolo
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Oncology (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Hematology (AREA)
- AIDS & HIV (AREA)
- Tropical Medicine & Parasitology (AREA)
- Molecular Biology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Los compuestos de la formula 1 en donde R1 es H, A, -[C(R6)2]nAr, -[C(R6)2]nHet o -[C(R6)2]ncicloalquilo, R2 es H, A, bencilo o CH2CH2OR6, R3, R4 son cada uno, de modo independiente entre sí, H, A, Hal, CN, -[C(R6)2]nAr, -[C(R6)2]nHet o -[C(R6)2]ncicloalquilo; R5 es H o alquilo C1-6, R6 es H o alquilo C1-6; A es alquilo no ramificado o ramificado C1-10, en donde uno o dos grupos CH2 pueden estar reemplazados por átomos de O o S y/o por grupas -CH=CH y/o también 1-7 atamos de H pueden estar reemplazados por F, cicloalquilo es alquilo cíclico C3-7, que adicionalmente puede estar sustituido con alquilo C1-6; Hal es F, Cl, Br o I; Ar es fenilo no sustituido o mono-, di- o trisustituido con Hal, A, OR6, N(R6)2, NO2, CN, COOR6, CON(R6)2, NR6COA, NR6SO2A, COR6, SO2N(R6)2 y/o S(O)pA, Het es un heterociclo saturado, insaturado o aromático mono- o bicíclico no sustituido o mono- o disustituido con Hal, A, OR6, N(R6)2, NO2, CN, COOR6, CON(R6)2, NR6COA, NR6SO2A, COR6, SO2NR6, S(O)pA y/u =O (oxigeno del carbonilo) con 1 a 4 átomos de N y/u O y/o S, n es 0, 1, 2, 3 o 4; p es 0, 1 o 2, así como sus sales, tautomeros y estereoisomeros de utilidad farmacéutica, incluyendo sus mezclas en todas las proporciones. Son inhibidores de la proliferacion celular / vitalidad celular y se pueden emplear para el tratamiento de tumores.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE102008005493A DE102008005493A1 (de) | 2008-01-22 | 2008-01-22 | 4-(Pyrrolo[2,3-c] pyridine-3-yl)-pyrimidin-2-yl-amin-derivate |
Publications (1)
Publication Number | Publication Date |
---|---|
AR070212A1 true AR070212A1 (es) | 2010-03-25 |
Family
ID=40386204
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP090100174A AR070212A1 (es) | 2008-01-22 | 2009-01-21 | Derivados de 4-(pirrolo[2,3-c]piridin-3-il)-pirimidinil-2-amina, proceso de preparacion, medicamentos que los contienen y usos de los mismos para el tratamiento de tumores, metastasis tumoral y/o sida. |
Country Status (14)
Country | Link |
---|---|
US (1) | US20100292262A1 (es) |
EP (1) | EP2231664A1 (es) |
JP (1) | JP5524864B2 (es) |
KR (1) | KR20100112626A (es) |
CN (1) | CN101918404A (es) |
AR (1) | AR070212A1 (es) |
AU (1) | AU2008348816B2 (es) |
BR (1) | BRPI0821936A2 (es) |
CA (1) | CA2712612A1 (es) |
DE (1) | DE102008005493A1 (es) |
IL (1) | IL206905A0 (es) |
MX (1) | MX2010007927A (es) |
WO (1) | WO2009092431A1 (es) |
ZA (1) | ZA201005959B (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101723936B (zh) * | 2008-10-27 | 2014-01-15 | 上海睿星基因技术有限公司 | 激酶抑制剂及其在药学中的用途 |
EP2714688B1 (en) | 2011-05-26 | 2016-02-24 | Daiichi Sankyo Company, Limited | Heterocyclic compounds as protein kinase inhibitors |
JP6412503B2 (ja) | 2012-11-21 | 2018-10-24 | ピーティーシー セラピューティクス, インコーポレイテッド | 置換逆ピリミジンBmi−1阻害剤 |
TWI663166B (zh) | 2013-04-24 | 2019-06-21 | 健生藥品公司 | 新化合物 |
WO2015030847A1 (en) * | 2013-08-30 | 2015-03-05 | Ptc Therapeutics, Inc. | Substituted pyrimidine bmi-1 inhibitors |
TWI627173B (zh) | 2013-09-26 | 2018-06-21 | 比利時商健生藥品公司 | 作為NIK抑制劑的新穎3-(1H-吡唑-4-基)-1H-吡咯并[2,3-c]吡啶衍生物 |
TWI704146B (zh) | 2013-09-26 | 2020-09-11 | 比利時商健生藥品公司 | 用作NIK抑制劑之新的1-(4-嘧啶基)-1H-吡唑並[3,2-c]吡啶衍生物 |
EP3071553A4 (en) | 2013-11-21 | 2017-08-02 | PTC Therapeutics, Inc. | Substituted pyridine and pyrazine bmi-1 inhibitors |
EA033236B1 (ru) | 2014-10-23 | 2019-09-30 | Янссен Фармацевтика Нв | Новые производные пиразола в качестве ингибиторов nik |
CA2960567C (en) | 2014-10-23 | 2023-03-07 | Janssen Pharmaceutica Nv | Thienopyrimidine derivatives as nik inhibitors |
EP3209662B1 (en) | 2014-10-23 | 2019-01-09 | Janssen Pharmaceutica N.V. | New compounds as nik inhibitors |
JP6616412B2 (ja) | 2014-10-23 | 2019-12-04 | ヤンセン ファーマシューティカ エヌ.ベー. | Nik阻害剤としての新規のピラゾロピリミジン誘導体 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747469A (en) | 1991-03-06 | 1998-05-05 | Board Of Regents, The University Of Texas System | Methods and compositions comprising DNA damaging agents and p53 |
GB9904387D0 (en) | 1999-02-25 | 1999-04-21 | Pharmacia & Upjohn Spa | Antitumour synergistic composition |
GB0308466D0 (en) | 2003-04-11 | 2003-05-21 | Novartis Ag | Organic compounds |
JP2008502687A (ja) * | 2004-06-14 | 2008-01-31 | タケダ サン ディエゴ インコーポレイテッド | キナーゼ阻害剤 |
US7855205B2 (en) * | 2004-10-29 | 2010-12-21 | Janssen Pharmaceutica Nv | Pyrimidinyl substituted fused-pyrrolyl compounds useful in treating kinase disorders |
EP2532667A1 (en) * | 2005-09-30 | 2012-12-12 | Vertex Pharmaceuticals Incorporated | Deazapurines useful as inhibitors of janus kinases |
DE102006012617A1 (de) * | 2006-03-20 | 2007-09-27 | Merck Patent Gmbh | 4-(Pyrrolopyridinyl)-pyrimidinyl-2-amin-derivate |
-
2008
- 2008-01-22 DE DE102008005493A patent/DE102008005493A1/de not_active Withdrawn
- 2008-12-23 US US12/863,817 patent/US20100292262A1/en not_active Abandoned
- 2008-12-23 AU AU2008348816A patent/AU2008348816B2/en not_active Ceased
- 2008-12-23 WO PCT/EP2008/011098 patent/WO2009092431A1/de active Application Filing
- 2008-12-23 BR BRPI0821936-2A patent/BRPI0821936A2/pt not_active IP Right Cessation
- 2008-12-23 CN CN200880125171XA patent/CN101918404A/zh active Pending
- 2008-12-23 CA CA2712612A patent/CA2712612A1/en not_active Abandoned
- 2008-12-23 KR KR1020107018575A patent/KR20100112626A/ko not_active Application Discontinuation
- 2008-12-23 MX MX2010007927A patent/MX2010007927A/es not_active Application Discontinuation
- 2008-12-23 EP EP08871371A patent/EP2231664A1/de not_active Withdrawn
- 2008-12-23 JP JP2010543386A patent/JP5524864B2/ja not_active Expired - Fee Related
-
2009
- 2009-01-21 AR ARP090100174A patent/AR070212A1/es unknown
-
2010
- 2010-07-08 IL IL206905A patent/IL206905A0/en unknown
- 2010-08-20 ZA ZA2010/05959A patent/ZA201005959B/en unknown
Also Published As
Publication number | Publication date |
---|---|
CN101918404A (zh) | 2010-12-15 |
BRPI0821936A2 (pt) | 2015-06-16 |
MX2010007927A (es) | 2010-08-09 |
WO2009092431A1 (de) | 2009-07-30 |
DE102008005493A8 (de) | 2010-03-25 |
ZA201005959B (en) | 2011-04-28 |
CA2712612A1 (en) | 2009-07-30 |
IL206905A0 (en) | 2010-12-30 |
AU2008348816A1 (en) | 2009-07-30 |
US20100292262A1 (en) | 2010-11-18 |
JP5524864B2 (ja) | 2014-06-18 |
AU2008348816B2 (en) | 2011-10-20 |
JP2011510028A (ja) | 2011-03-31 |
KR20100112626A (ko) | 2010-10-19 |
EP2231664A1 (de) | 2010-09-29 |
DE102008005493A1 (de) | 2009-07-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR070212A1 (es) | Derivados de 4-(pirrolo[2,3-c]piridin-3-il)-pirimidinil-2-amina, proceso de preparacion, medicamentos que los contienen y usos de los mismos para el tratamiento de tumores, metastasis tumoral y/o sida. | |
AR067081A1 (es) | Derivados de pirrolo[2,3-b]piridin-pirimidina,proceso de preparacion, medicamentos que los contienen y usos de los mismos para el tratamiento de tumores cancerigenos y metastasis tumorales. | |
AR072860A1 (es) | Derivados de 3-(3-pirimidin-2-il-bencil)-[1,2,4]triazolo[4,3-b]piridazina | |
AR067506A1 (es) | Derivados de quinazolinamida | |
AR096235A1 (es) | Arilquinazolinas | |
AR068658A1 (es) | Derivados de tiazol | |
AR059908A1 (es) | Derivados de 4-(pirrolopiridinil)-pirimidinil-2-amina | |
AR071208A1 (es) | Derivados de piridazinona | |
AR059488A1 (es) | Hidrazidas de acido mandelico | |
AR076006A1 (es) | Compuestos heterociclicos inhibidores de autotaxina utiles para el tratamiento de tumores, proceso para prepararlos y medicamentos que los contienen. | |
AR077567A1 (es) | Derivados de aminopiridina | |
AR076750A1 (es) | Derivados de 3-((1,2,3) triazol -4-il)- pirrolo (2,3-b) piridina | |
AR066543A1 (es) | Derivados de piridazinona | |
AR074418A1 (es) | Compuestos de benzonaftiridina, procedimiento de preparacion y su uso en el tratamiento de tumores | |
PE20160126A1 (es) | Derivados del bipirazol como inhibidores jak | |
AR073055A1 (es) | Derivados biciclicos de triazol | |
AR083670A1 (es) | DERIVADOS DE 7-([1,2,3]TRIAZOL-4-IL)-PIRROLO[2,3-b]PIRAZINA UTILES COMO INHIBIDORES DE LA PROLIFERACION CELULAR, COMPOSICIONES FARMACEUTICAS QUE LOS CONTIENEN Y PROCEDIMIENTO PARA PREPARARLOS | |
AR090488A1 (es) | Derivados de n-ciclobutilbenzamida, un proceso para su obtencion, intermediarios para su sintesis, composiciones pesticidas y farmaceuticas que los comprenden y metodos para controlar daños debidos a una plaga y/u hongos | |
AR055376A1 (es) | Derivados de 1-acildihidropirazol | |
AR082722A1 (es) | Derivados de pirimidina | |
PE20160875A1 (es) | Compuestos de biaril-amida como inhibidores de cinasa | |
AR081828A1 (es) | Compuestos de biguanida y su uso para el tratamiento del cancer | |
AR061913A1 (es) | Derivados de aminoindazolurea, procesos de obtencion y composiciones farmaceuticas. | |
AR092869A1 (es) | Alcoxipirazoles como activadores de guanilato ciclasa soluble | |
AR088857A1 (es) | Compuestos de 1,2,5-oxadiazol sustituido y su uso como herbicidas |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |